CODX vs HOOD · rev $3.9M vs P/E 48, rev $4.47B
Co-Diagnostics, Inc. Common Stock (CODX) versus Robinhood Markets Inc (HOOD) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Robinhood Markets Inc (HOOD) is a capital markets company listed on NASDAQ. It is led by Vlad Tenev.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported HOOD revenue for 2025-12-31 was $4.47B. Net income was $1.88B. Revenue was up 51.6% from 2024-12-31 to 2025-12-31. HOOD currently screens at market cap $88.36B and trailing P/E 47.6.
CODX currently screens at market cap $31.4M. HOOD currently screens at market cap $88.36B and trailing P/E 47.6.
Not investment advice. Open the CODX and HOOD stock pages for the full models.
Not investment advice.